Our feature-rich products and expert services help hundreds of organizations, including leading global companies, drive bottom line results by improving, automating and optimizing their source-to-settle processes. To join the conversation, please visit the SciQuest Blog.

Q3 2015 The Scotts Miracle-Gro Company Earnings Conference Call. Tuesday, August 04, 2015. Q3 2015 The Scotts Miracle-Gro Company Earnings Conference Call. Click here to add this event to your calendar. ScottsMiracle-Gro Announces Third Quarter Results; Re-Affirms Full-Year Earnings Outlook. The Scotts Miracle-Gro Company Increases Quarterly Dividend Payment.

Listed holdings where we are lead owner. Long ownership horizon and value creation from dividends, value appreciation and cash flow. Our wholly-owned subsidiaries, partner-owned investments and other investments. We have a long-term perspective for all investments. We always act in the best interest of our portfolio companies by fully supporting them in their efforts to create sustainable value.

Transforming cancer treatment and advancing new therapies through empowered science. Seattle Genetics is a biotechnology company focused on developing and commercializing innovative, empowered antibody-based therapies for the treatment of cancer. Seattle Genetics Reports Second Quarter 2015 Financial Results.

View articles for various topics. Information to public on complaints. Scheme for conduct of Awareness Programs for Commodities Derivatives. National Strategy for Financial Education. Securities and Exchange Board of India. Insurance Regulatory and Development Authority. Listed Companies Status - SCORES.